Header Logo

Michael Jelinek

Concepts (241)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
5
2023
135
2.380
Why?
Coronary Disease
9
2015
87
1.710
Why?
Protein Kinase Inhibitors
3
2020
55
1.500
Why?
Cisplatin
2
2023
92
1.450
Why?
Cardiovascular Diseases
6
2020
411
1.360
Why?
Secondary Prevention
5
2020
64
1.320
Why?
Cardiology
5
2021
73
1.280
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2021
329
1.200
Why?
Cardiac Rehabilitation
4
2021
9
1.150
Why?
Lung Neoplasms
3
2021
636
1.090
Why?
Coronary Artery Disease
4
2017
125
1.000
Why?
Acute Coronary Syndrome
4
2021
15
0.900
Why?
Acrylamides
2
2020
5
0.870
Why?
Aniline Compounds
2
2020
41
0.870
Why?
Humans
45
2023
29814
0.800
Why?
Exercise Test
3
2018
124
0.790
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2021
4
0.760
Why?
Carboplatin
1
2021
48
0.750
Why?
Benzimidazoles
1
2021
11
0.750
Why?
Heart Failure
7
2021
207
0.750
Why?
Standard of Care
1
2020
10
0.740
Why?
Paclitaxel
1
2021
74
0.740
Why?
Biological Specimen Banks
1
2019
5
0.700
Why?
Carcinoma, Non-Small-Cell Lung
2
2021
321
0.690
Why?
Antineoplastic Agents, Immunological
1
2019
20
0.670
Why?
Medicine
2
2008
11
0.650
Why?
Physicians, Family
2
2008
8
0.640
Why?
Specialization
2
2008
17
0.640
Why?
Lipocalin-2
1
2018
2
0.630
Why?
Cardiorespiratory Fitness
1
2018
16
0.630
Why?
Cystatin C
1
2018
3
0.630
Why?
Life Style
3
2019
212
0.610
Why?
Acute Kidney Injury
1
2018
49
0.600
Why?
Mutation
1
2019
396
0.590
Why?
Hydrocarbons, Fluorinated
1
2017
3
0.580
Why?
Taxoids
1
2017
14
0.580
Why?
Antineoplastic Agents
1
2019
252
0.570
Why?
Hypertension
2
2019
272
0.570
Why?
Apoptosis
2
2022
259
0.570
Why?
Practice Guidelines as Topic
2
2018
334
0.550
Why?
Cell Proliferation
1
2017
206
0.540
Why?
ErbB Receptors
3
2023
73
0.540
Why?
Aged
20
2023
9620
0.500
Why?
Depression
3
2018
472
0.500
Why?
Neoplasms
1
2018
257
0.500
Why?
Coronary Artery Bypass
1
2014
31
0.480
Why?
Myocardial Ischemia
1
2014
49
0.460
Why?
Patient Education as Topic
2
2013
161
0.460
Why?
Return to Work
1
2014
52
0.460
Why?
Vulnerable Populations
1
2013
24
0.460
Why?
Middle Aged
17
2021
9960
0.450
Why?
Risk Reduction Behavior
1
2013
55
0.440
Why?
Breast Neoplasms
1
2017
352
0.440
Why?
Male
20
2023
15851
0.440
Why?
Female
19
2021
16412
0.400
Why?
Critical Pathways
1
2011
22
0.380
Why?
Delivery of Health Care, Integrated
1
2011
26
0.370
Why?
Program Evaluation
3
2017
135
0.370
Why?
Psychiatric Status Rating Scales
1
2011
351
0.350
Why?
Risk Factors
11
2019
2465
0.340
Why?
Chest Pain
1
2009
24
0.340
Why?
Mass Screening
1
2011
180
0.340
Why?
Prognosis
4
2021
874
0.340
Why?
Smartphone
2
2021
15
0.330
Why?
Australia
8
2021
46
0.330
Why?
Models, Statistical
1
2009
132
0.330
Why?
Medication Adherence
1
2009
79
0.320
Why?
Exercise Therapy
2
2021
112
0.310
Why?
Biomarkers
3
2020
704
0.300
Why?
Young Adult
4
2021
1966
0.290
Why?
Death, Sudden
1
2006
14
0.280
Why?
Quality of Life
4
2021
677
0.270
Why?
Adult
8
2021
8741
0.240
Why?
Prospective Studies
6
2018
1823
0.240
Why?
Risk Assessment
5
2019
683
0.240
Why?
Platelet Aggregation Inhibitors
2
2018
50
0.240
Why?
Radiotherapy, Intensity-Modulated
1
2023
33
0.220
Why?
Prevalence
2
2019
494
0.220
Why?
Laryngeal Neoplasms
1
2023
29
0.220
Why?
Cetuximab
1
2023
8
0.220
Why?
Counseling
2
2017
47
0.210
Why?
Nose Neoplasms
1
2022
34
0.210
Why?
Cell-Derived Microparticles
1
2022
7
0.200
Why?
Paranasal Sinus Neoplasms
1
2022
53
0.200
Why?
Radiosurgery
1
2021
34
0.190
Why?
Aged, 80 and over
7
2019
4930
0.190
Why?
DDT
1
2020
1
0.190
Why?
Insulin-Secreting Cells
1
2020
6
0.190
Why?
Carcinoma, Squamous Cell
1
2022
180
0.180
Why?
Comorbidity
4
2021
504
0.170
Why?
Retrospective Studies
5
2023
3325
0.170
Why?
Proteomics
1
2020
93
0.170
Why?
United Kingdom
1
2019
51
0.170
Why?
Blood Circulation
1
2019
3
0.170
Why?
Liquid Biopsy
1
2019
3
0.170
Why?
Circulating Tumor DNA
1
2019
3
0.170
Why?
DNA Mutational Analysis
1
2019
57
0.170
Why?
Societies, Medical
2
2020
190
0.170
Why?
Walking Speed
1
2019
41
0.170
Why?
Diastole
1
2019
36
0.170
Why?
France
1
2019
36
0.170
Why?
Waist Circumference
1
2019
36
0.170
Why?
Molecular Targeted Therapy
1
2019
36
0.170
Why?
Obesity, Abdominal
1
2019
22
0.170
Why?
Stroke Volume
1
2019
61
0.160
Why?
Ventricular Function, Left
1
2019
49
0.160
Why?
Natriuretic Peptide, Brain
1
2019
11
0.160
Why?
Treatment Outcome
5
2021
3561
0.160
Why?
Drug Resistance, Neoplasm
1
2019
77
0.160
Why?
Bias
2
2008
34
0.160
Why?
Mouth
1
2018
12
0.160
Why?
Infection Control
1
2020
174
0.160
Why?
American Heart Association
1
2018
29
0.160
Why?
Peptide Fragments
1
2019
96
0.160
Why?
Pharynx
1
2018
14
0.160
Why?
Predictive Value of Tests
3
2019
532
0.160
Why?
Hemorrhage
1
2018
75
0.150
Why?
Coronavirus Infections
1
2020
86
0.150
Why?
Pneumonia, Viral
1
2020
89
0.150
Why?
Glomerular Filtration Rate
1
2018
59
0.150
Why?
Pandemics
1
2020
237
0.150
Why?
Aspirin
1
2018
84
0.150
Why?
Myocardial Infarction
1
2018
175
0.150
Why?
Plaque, Atherosclerotic
1
2017
25
0.150
Why?
Caspases
1
2017
33
0.150
Why?
Coronary Vessels
1
2017
46
0.140
Why?
Tumor Cells, Cultured
1
2017
149
0.140
Why?
Exercise
1
2021
474
0.140
Why?
Geriatric Assessment
1
2018
221
0.140
Why?
Health Behavior
3
2021
159
0.140
Why?
Signal Transduction
1
2019
492
0.140
Why?
Blotting, Western
1
2017
175
0.140
Why?
Cohort Studies
2
2019
1952
0.140
Why?
Body Mass Index
1
2019
425
0.140
Why?
Telephone
2
2014
27
0.130
Why?
United States
3
2018
2344
0.130
Why?
Cross-Sectional Studies
1
2019
970
0.130
Why?
Patient Compliance
3
2016
165
0.130
Why?
Biomarkers, Tumor
1
2017
198
0.130
Why?
Depressive Disorder
2
2015
191
0.120
Why?
Elective Surgical Procedures
1
2013
42
0.110
Why?
Calcium
1
2017
496
0.110
Why?
Preoperative Care
1
2013
135
0.110
Why?
New Zealand
3
2020
13
0.110
Why?
Heart Diseases
1
2013
75
0.110
Why?
Evidence-Based Medicine
2
2011
214
0.100
Why?
Affect
1
2011
65
0.090
Why?
Bayes Theorem
1
2009
39
0.090
Why?
Medical Audit
1
2009
7
0.090
Why?
Family Practice
1
2009
20
0.090
Why?
Hospitals, Teaching
1
2009
33
0.080
Why?
Unnecessary Procedures
1
2009
24
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
27
0.080
Why?
Adrenergic beta-Antagonists
1
2009
42
0.080
Why?
Exercise Tolerance
2
2021
32
0.080
Why?
Program Development
1
2009
70
0.080
Why?
Telemedicine
1
2011
99
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
64
0.080
Why?
Electrocardiography
1
2009
219
0.080
Why?
Postoperative Complications
1
2013
957
0.070
Why?
Life Expectancy
1
2006
19
0.070
Why?
Myocardial Revascularization
1
2006
18
0.070
Why?
Incidence
2
2019
759
0.070
Why?
Cholesterol
2
2003
54
0.060
Why?
Survival Rate
1
2006
376
0.060
Why?
Hypercholesterolemia
2
2002
29
0.060
Why?
Follow-Up Studies
3
2018
1859
0.060
Why?
Time Factors
1
2009
1641
0.060
Why?
Printing, Three-Dimensional
1
2023
5
0.060
Why?
Immobilization
1
2023
14
0.060
Why?
Laryngectomy
1
2023
17
0.060
Why?
Salvage Therapy
1
2023
36
0.060
Why?
Neck
1
2023
33
0.060
Why?
Victoria
2
2019
6
0.060
Why?
Chemoradiotherapy
1
2023
69
0.050
Why?
Patient-Centered Care
1
2003
61
0.050
Why?
Radiotherapy Planning, Computer-Assisted
1
2023
68
0.050
Why?
Positron Emission Tomography Computed Tomography
1
2022
21
0.050
Why?
Cardiovascular Agents
2
2013
29
0.050
Why?
Biology
1
2022
7
0.050
Why?
Anticholesteremic Agents
1
2002
20
0.050
Why?
Ipilimumab
1
2021
4
0.050
Why?
Walk Test
1
2021
10
0.050
Why?
Early Medical Intervention
1
2021
15
0.050
Why?
Length of Stay
1
2023
320
0.050
Why?
Neoplasm Recurrence, Local
1
2022
200
0.050
Why?
Electrophoresis, Gel, Two-Dimensional
1
2020
9
0.050
Why?
Mass Spectrometry
1
2020
41
0.050
Why?
Pilot Projects
1
2022
403
0.050
Why?
Cell Survival
1
2020
165
0.040
Why?
Cell Line
1
2020
299
0.040
Why?
Health Promotion
1
2002
162
0.040
Why?
Recovery of Function
1
2021
291
0.040
Why?
Consensus
1
2020
109
0.040
Why?
Symptom Assessment
1
2019
21
0.040
Why?
Betacoronavirus
1
2020
75
0.040
Why?
Gene Expression Regulation
1
2020
282
0.040
Why?
ROC Curve
1
2019
140
0.040
Why?
Delivery of Health Care
1
2020
156
0.040
Why?
Echocardiography
1
2019
173
0.040
Why?
Tomography, X-Ray Computed
1
2022
778
0.040
Why?
Administration, Oral
1
2018
144
0.040
Why?
Treatment Failure
1
2018
161
0.040
Why?
Insurance, Health
1
2017
22
0.040
Why?
Propensity Score
1
2017
34
0.040
Why?
Sex Factors
1
2019
497
0.040
Why?
Cost-Benefit Analysis
1
2017
143
0.040
Why?
Residence Characteristics
1
2019
216
0.040
Why?
Double-Blind Method
1
2018
522
0.040
Why?
Survival Analysis
1
2017
310
0.040
Why?
Patient Acceptance of Health Care
1
2017
79
0.030
Why?
Disease Management
1
2017
122
0.030
Why?
Text Messaging
1
2016
14
0.030
Why?
Age Factors
1
2019
853
0.030
Why?
Single-Blind Method
1
2016
120
0.030
Why?
Case-Control Studies
1
2017
641
0.030
Why?
Independent Living
1
2018
285
0.030
Why?
Severity of Illness Index
1
2019
1126
0.030
Why?
Anxiety
1
2015
157
0.030
Why?
Social Support
1
2015
186
0.030
Why?
Risk Adjustment
1
2013
12
0.030
Why?
Percutaneous Coronary Intervention
1
2013
23
0.030
Why?
Decision Support Techniques
1
2013
51
0.030
Why?
Health Status Indicators
1
2013
78
0.030
Why?
Hypolipidemic Agents
2
2003
22
0.030
Why?
Cardiac Surgical Procedures
1
2011
43
0.020
Why?
Clinical Protocols
1
2011
64
0.020
Why?
Feasibility Studies
1
2011
230
0.020
Why?
Aftercare
1
2006
23
0.020
Why?
Ventricular Dysfunction, Left
1
2006
42
0.020
Why?
Cardiac Pacing, Artificial
1
2006
84
0.020
Why?
Physical Examination
1
2006
117
0.020
Why?
Palliative Care
1
2006
149
0.020
Why?
Allied Health Personnel
1
2003
12
0.010
Why?
Nursing Staff, Hospital
1
2003
61
0.010
Why?
Europe
1
2002
85
0.010
Why?
Chi-Square Distribution
1
2002
147
0.010
Why?
Analysis of Variance
1
2002
325
0.010
Why?
Multivariate Analysis
1
2002
332
0.010
Why?
Diabetes Mellitus, Type 2
1
2002
201
0.010
Why?
Obesity
1
2002
290
0.010
Why?
Jelinek's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (241)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_